Smart Respiratory

About

Smart Respiratory was established at Imperial College London, with the mission to improve the lives of asthmatics using Artificial Intelligence and digital health and was the first company in the world to offer a digital peak flow meter that connects directly to a smartphone. Smart Asthma Monitoring was initially launched for self-management of asthma using a smartphone, using sensors and an app to measure peak flow, symptoms and rescue inhaler use, together with an algorithm to predict the patient’s asthma for tomorrow and predict asthma attacks and exacerbations. The patient shares this data with the clinician via email.
Since the pandemic, the adoption of digital health has accelerated and we added a telemedicine solution, where patients share their data with clinicians via a dashboard 24/7. Clinicians can identify when patients’ asthma starts to worsen and amend medication accordingly, instead of waiting until hospitalisation or the regular face to face consultation. Smart Respiratory believe that more data means better clinical decision and leads to fewer asthma attacks and hospital admissions.
Smart Respiratory collaborate with the NHS, together with hospitals, clinics, pharmaceutical companies, pharmacy chains and ecommerce platforms worldwide to provide affordable digital health solutions for asthmatics.

Key Facts

1) https://www.ed.ac.uk/usher/aukcar/news/news-stories/2022/asthma-attacks-cut-by-half-digital-tools – Digital interventions that help people take their asthma medication better may cut the risk of asthma attacks by half, review finds. 2) Asthma is a non-curable, lifelong condition, it doesn’t go away, you just have to manage it. 3) 350m people living with asthma and kills approximately 250,000 a year worldwide. 4) Asthma is the most common chronic disease amongst children.

Successes in UK/NHS

Smart Asthma Monitoring is currently being used by the following Trusts: Frimley, Isle of Wight, Maidstone and Tunbridge Wells, Wexham, Worcester, Great Western Hospitals, Royal Devon and Exeter, Chelsea and Westminster, Imperial College Healthcare and Tayside. Some of the Trusts are using Smart Asthma Monitoring in situ and others as part of service evaluations, both for paediatric and adult asthmatics.

Company details

Solutions

Delivering advanced patient care

Enabling self-care

Specialism

Long-term condition monitoring

Specialised self-care (except mental health)

Company details

Want to connect with this innovator?

Make an enquiry

Markets already exporting to

EU, India, Bangladesh, Taiwan, Australia, New Zealand, Argentina, Chile, Turkey, Serbia, Ukraine, Morocco, Egypt, South Africa, UAE

Desired Markets

Japan, South Korea, USA, Canada

Desired customer types

Hospitals, government health systems, pharmaceutical companies, pharmacy chains, CROs

Want to connect with this innovator?
Make an enquiry
Close
This field is required
This field is required
This field is required
This field is required
This field is required

Thank you

We are processing your request and will return your contact as soon as possible.